Purpose: is investigate the potential use of soluble TREM-1 (sTREM-1) as a marker of SIRS intensity and criterion for early postoperative complications prediction after on-pump coronary artery bypass surgery (CABG). This evidence concerns the gene TREM1 and systemic inflammatory response syndrome.